We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

15 hedge funds and large institutions have $7.32M invested in Tenax Therapeutics in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

7% more funds holding

Funds holding: 14 → 15 (+1)

1% more capital invested

Capital invested by funds: $7.21M → $7.32M (+$107K)

0% less ownership

Funds ownership: 0.02% → 0.01% (-0%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$355K
2
State Street
State Street
Massachusetts
+$269K
3
Morgan Stanley
Morgan Stanley
New York
+$76.1K
4
Northern Trust
Northern Trust
Illinois
+$34.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$9.51K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.1M
2
BlackRock
BlackRock
New York
-$171K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$19K
4
William Blair & Company
William Blair & Company
Illinois
-$19K
5
VFA
Valeo Financial Advisors
Indiana
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$4.2M – – –
BlackRock
2
BlackRock
New York
$1.06M -$171K -54 -14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$742K +$355K +112 +101%
Renaissance Technologies
4
Renaissance Technologies
New York
$400K -$1.1M -347 -74%
State Street
5
State Street
Massachusetts
$296K +$269K +85 New
FWP
6
FAS Wealth Partners
Kansas
$127K – – –
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$113K -$19K -6 -16%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$111K -$3.17K -1 -3%
Morgan Stanley
9
Morgan Stanley
New York
$80K +$76.1K +24 New
Northern Trust
10
Northern Trust
Illinois
$72K +$34.9K +11 +100%
Ameriprise
11
Ameriprise
Minnesota
$62K – – –
Citadel Advisors
12
Citadel Advisors
Florida
$44K +$9.51K +3 +30%
TRCT
13
Tower Research Capital (TRC)
New York
$3K +$3.17K +1 New
BCV
14
Banque Cantonale Vaudoise
Switzerland
$2K – – –
UBS Group
15
UBS Group
Switzerland
$2K – – –
William Blair & Company
16
William Blair & Company
Illinois
– -$19K -6 Closed
VFA
17
Valeo Financial Advisors
Indiana
– -$10K -3 Closed

TENX Hedge Fund Activity: Q2 2021 in Review

15 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2021, worth a combined $7.32M — up 1.5% from $7.21M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TENX positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $355K. The largest seller was Renaissance Technologies, cutting an estimated $1.1M.

  • 15 institutional investors held Tenax Therapeutics (TENX) as of Q2 2021, up from 14 in Q1 2021.
  • Funds reported $7.32M of Tenax Therapeutics stock for Q2 2021, up 1.5% quarter-over-quarter.
  • 3 funds opened new Tenax Therapeutics positions in Q2 2021 and 2 closed out, a net change of +1 holder.
  • The largest Tenax Therapeutics buyer in Q2 2021 was Vanguard Group, an estimated $355K added.
  • The largest Tenax Therapeutics seller in Q2 2021 was Renaissance Technologies, an estimated $1.1M sold.

Based on aggregated 13F filings for Q2 2021.